Risk of acute liver injury associated with the use of drugs: a multicentre population survey
- 9 April 2007
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 25 (12) , 1401-1409
Abstract
Summary: Background Acute liver injury of uncertain aetiology is often drug related and quantitative information about the associated risk is scarce.Aim To estimate the risk of acute liver injury associated with the use of drugs.Methods In a population survey study, 126 cases of acute liver injury were prospectively assembled from January 1993 to December 1999, in patients over 15 years of age, in 12 hospitals in Barcelona (Spain). We estimated the relative risk for each drug as the ratio between the incidence of acute liver injury among the exposed population to the drug and the incidence of acute liver injury among those not exposed to it. Drug consumption data were used to estimate the exposed population.Results Isoniazid, pyrazinamide, rifampicin, amoxicillin with clavulanic acid, erythromicin, chlorpromazine, nimesulide, and ticlopidine presented the highest risk (point relative risk > 25). Amoxicillin, metoclopramide, captopril and enalapril, furosemide, hydrochlorothiazide, fluoxetine, paroxetine, diazepam, alprazolam, lorazepam, metamizole, low‐dose acetylsalicylic acid and salbutamol showed the lowest risk (point relative risk < 5).Conclusions This study provides a risk estimation of serious liver disease for various drugs that will be useful in its diagnosis and management, and when comparing with the drug therapeutic benefit in each indication. Some observed associations would be worth specific studies.Keywords
This publication has 28 references indexed in Scilit:
- Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year PeriodGastroenterology, 2005
- Acute and clinically relevant drug‐induced liver injury: a population based case‐control studyBritish Journal of Clinical Pharmacology, 2004
- Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugsJournal of Hepatology, 2002
- Timing of New Black Box Warnings and Withdrawals for Prescription MedicationsJAMA, 2002
- Case-Population Studies in PharmacoepidemiologyDrug Safety, 2002
- Drug-induced acute liver diseasePharmacoepidemiology and Drug Safety, 1993
- The Increased Risk of Hospitalizations for Acute Liver Injury in a Population with Exposure to Multiple DrugsEpidemiology, 1993
- The role of non-steroidal anti-inflammatory drugs in acute liver injury.BMJ, 1992
- Drug‐induced hepatic injury: an analysis of 1100 cases reported to The Danish Committee on Adverse Drug Reactions between 1978 and 1987Journal of Internal Medicine, 1992
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990